YS

Yoshihiko Sano

Standing Corporate Auditor

KOBAYASHI Pharmaceutical

Roles

Standing Corporate AuditoratKOBAYASHI Pharmaceutical
DirectoratNippon Shinyaku
Representative Director, President & Chief Executive OfficeratNipro Corporation

KOBAYASHI Pharmaceutical Pipeline

DrugIndicationPhase
Muhi SeriesInsect bites, skin inflammation, itchingApproved/Commercial
Aneron SeriesGastrointestinal discomfort, indigestionApproved/Commercial
Bathclin SeriesBath additives for relaxation/skin careApproved/Commercial
Clear Clean SeriesAcne care, skin cleansingApproved/Commercial
Kobayashi Aerosol InhalerNasal congestion, cold symptomsApproved/Commercial